Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deutsche Bank starts Tesco at 'buy', Sainsbury's at 'hold'

(Sharecast News) - Deutsche Bank initiated coverage of Tesco and Sainsbury's on Tuesday with 'buy' and 'hold' ratings, respectively, as it said it was constructive on the food retail sector. "Competitive dynamics and cost pressures continue to shape the sector, however the UK's largest supermarkets, Tesco and Sainsbury's, are managing to defend their value and market share positions," the bank said.

"We see Tesco as better placed to navigate these dynamics, backed by operational efficiency, scale and purchasing power.

"Online growth and powerful Clubcard flywheel are also competitive advantages with long-term monetisation opportunity."

Deutsche Bank said Sainsbury's re-focus on food and value has strengthened its position.

"However, lower margins, sales densities and employee efficiency may make current dynamics tougher to navigate," it said. The Argos exposure also raises cyclical risks, DB added.

The bank said its Tesco earnings per share forecasts are around 5% ahead of consensus but it's broadly in line for Sainsbury's.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.